Drugs / JKN2306
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07412938 | Feb → Jul 2025 | — | Joincare Pharmaceutical Group Industry Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JKN2306 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07412938 ↗ |
| Action | Inhibit | “highly selective Nav1.8 inhibitor” PMID 42290196 ↗ Jun 2026 |
| Route | Oral | “single oral dose of JKN2306” PMID 42290196 ↗ Jun 2026 |